These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22499828)

  • 1. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
    Göke F; Franzen A; Menon R; Goltz D; Kirsten R; Boehm D; Vogel W; Göke A; Scheble V; Ellinger J; Gerigk U; Fend F; Wagner P; Schroeck A; Perner S
    Chest; 2012 Oct; 142(4):1020-1026. PubMed ID: 22499828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
    Lim SH; Sun JM; Choi YL; Kim HR; Ahn S; Lee JY; Lee SH; Ahn JS; Park K; Kim JH; Cho BC; Ahn MJ
    Cancer; 2016 Oct; 122(19):3024-31. PubMed ID: 27315356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
    Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
    Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
    Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.
    Flockerzi FA; Roggia C; Langer F; Holleczek B; Bohle RM
    Virchows Arch; 2018 May; 472(5):759-769. PubMed ID: 29270870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
    Cihoric N; Savic S; Schneider S; Ackermann I; Bichsel-Naef M; Schmid RA; Lardinois D; Gugger M; Bubendorf L; Zlobec I; Tapia C
    Br J Cancer; 2014 Jun; 110(12):2914-22. PubMed ID: 24853178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With Ponatinib.
    Ng TL; Yu H; Smith DE; Boyle TA; York ER; Leedy S; Gao D; Aisner DL; Van Bokhoven A; Heasley LE; Hirsch FR; Camidge DR
    Clin Lung Cancer; 2019 Jan; 20(1):e39-e51. PubMed ID: 30297175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
    Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
    Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ
    J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
    Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
    Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).
    Guo Q; Sun Y; Yu S; Bai H; Zhao J; Zhuo M; Wang J
    Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.